BENEFITS AND RISKS OF USING ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC) PATIENTS: RESULTS FROM STUDY-LEVEL AND PATIENT-LEVEL META-ANALYSES OF CONTROLLED ESA TRIALS IN LUNG CANCER

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Vansteenkiste, J; Glaspy, J; Henry, D; Ludwig, H; Pirker, R; Tomita, D; Collins, H; Crawford, J

Published Date

  • June 1, 2011

Published In

Volume / Issue

  • 6 / 6

Start / End Page

  • S645 - S646

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1556-1380

International Standard Serial Number (ISSN)

  • 1556-0864